Search
Displaying 41–50 of 1175 results
-
- Sep 9, 2026
- 6:00 p.m. - 8:00 p.m. (EDT)
- 22 Sears St, Burlington, MA 01803
Community EventJoin us for New England Vision Connection
-
- Sep 9, 2026
- 5:30 p.m. - 7:30 p.m. (EDT)
- 200 Kelton Ave, Columbus, OH 43205
Community EventJoin the Foundation Fighting Blindness for Vision Connection, an enriching and supportive gathering across the Foundation Chapter network for the blind and low vision community.
-
- Sep 9, 2026 - Sep 11, 2026
- 5:00 p.m. - 1:00 p.m.
- 10950 N. Torrey Pines Road, La Jolla, CA 92037
Foundation EventThe Foundation Fighting Blindness, together with the Nixon Visions Foundation, invites you to join a free, in-person workshop bringing together individuals and families affected by PRPH2 and associated retinal diseases, along with researchers, physicians, and industry partners.
-
Cincinnati/Northern Kentucky Vision Connection
- Sep 2, 2026
- 5:30 p.m. - 7:30 p.m. (EDT)
- 3301 Madison Rd, Cincinnati, OH 45209
Community EventJoin the Foundation Fighting Blindness for Vision Connection, an enriching and supportive gathering across the Foundation Chapter network for the blind and low vision community.
-
Research News
Cell therapy DSP-3077 is in Phase 1/2a clinical trials
-
Tarsus plans to purchase Alkeus, developer of emerging Stargardt treatment
Research NewsDeal marks another step as gildeuretinol advances towards patients
-
Jackson's New Discoveries After LUXTURNA
Beacon StoriesAfter receiving LUXTURNA at age 9, Jackson Kennedy began experiencing everyday moments he had never been able to see before—from ice cubes floating in a glass to traffic moving through a city street. Today, Jackson is an honor roll student and dedicated wrestler looking ahead to college, while embracing the possibilities his treatment has helped make possible.
-
PRIMA retinal implant restores sight in patients with geographic atrophy from AMD
Research NewsProduct launched in Europe, U.S. approval in progress
-
FDA accepts new drug application, prioritizes review for potential Stargardt treatment
Research NewsBelite Bio’s tinlarebant could become the first-ever approved treatment for Stargardt disease
-
Beacon Stories
Since becoming involved with the Foundation Fighting Blindness 10 years ago, Brenda has become a dedicated leader, advocate and champion for the community. Whether welcoming someone newly diagnosed, leading the Fort Wayne Chapter or participating in a clinical trial to help advance research, Brenda has dedicated herself to creating more hope and opportunity for others.
